FDA Inspection 1232425 — J. Robert Flamini, MD

J. Robert Flamini, MD — FEI 3014137184

The FDA completed an inspection of J. Robert Flamini, MD on March 11, 2024 in Atlanta, GA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance